Thyrocare Technologies share news, announcements and annual reports
NSE: THYROCAREBSE: 539871Healthcare ServicesSmall Cap
Thyrocare Technologies Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 2016 · Issue price ₹446
Last close ₹456.30down ₹59.20 (11.48%)BSE ₹457.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹515.50.
30 Oct: open ₹496.05, high ₹503.50, low ₹445.30
52-week range of traded prices to 30 Oct 2026
₹342.55Low, 23 Mar 2026₹662.00High, 12 Aug 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹7,263 Cr673rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 50.36
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹51 crore of one-off items, the largest of them in the quarter to Sep 2026.
- 37.18
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 13.12
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.53%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 26.5%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹51 crore of one-off items, the largest of them in the quarter to Sep 2026.
- 35.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 43.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 60,51,03840.9% delivered
Thyrocare Technologies analyst meets
206 filed, newest first. Page 1 of 5.
Oct 2026
22 Oct · Analysts
Jul 2026
16 Jul · Analysts
May 2026
7 May · Analysts
4 May · Analysts
Apr 2026
29 Apr · Analysts
Jan 2026
Oct 2025
6 Oct · Analysts
Jul 2025
16 Jul · Analysts
Apr 2025
15 Apr · Analysts
Jan 2025
Oct 2024
16 Oct · Analysts
Jul 2024
17 Jul · Analysts
May 2024
7 May · Analysts
Jan 2024
24 Jan · Analysts
Dec 2023
4 Dec · Analysts
Nov 2023
15 Nov · Analysts
Oct 2023
25 Oct · Analysts
Aug 2023
31 Aug · Analysts
25 Aug · Analysts
1 Aug · Analysts
Jul 2023
31 Jul · Analysts
28 Jul · Analysts
26 Jul · Analysts
20 Jul · Analysts
20 Jul · Analysts
10 Jul · Analysts
5 Jul · Analysts
Jun 2023
3 Jun · Analysts
May 2023
29 May · Analysts
17 May · Analysts
3 May · Analysts
Apr 2023
25 Apr · Analysts
19 Apr · Analysts
13 Apr · Analysts
Mar 2023
13 Mar · Analysts
8 Mar · Analysts
Feb 2023
27 Feb · Analysts
27 Feb · Analysts
20 Feb · Analysts
16 Feb · Analysts
4 Feb · Analysts
Jan 2023
28 Jan · Analysts
3 Jan · Analysts
Dec 2022
13 Dec · Analysts
Nov 2022
28 Nov · Analysts
25 Nov · Analysts
23 Nov · Analysts
12 Nov · Analysts
3 Nov · Analysts
Sep 2022
23 Sep · Analysts